Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

heart-2372134_640

Sanofi and Regeneron’s Praluent approved in Europe to reduce CV risk

March 18, 2019
Research and Development, Sales and Marketing Regeneron, Sanofi, cardiovascular, heart, praluent

Sanofi and Regeneron’s Praluent (alirocumab) has been awarded approval by the European Commission, it has emerged, as a therapy to …

News
dupixentpackage

FDA expands Dupixent indication to include moderate-to-severe atopic dermatitis in adolescent patients

March 12, 2019
Manufacturing and Production, Sales and Marketing Dupixent, Regeneron, Sanofi, pharma

Partners Sanofi and Regeneron have both revealed that their jointly developed drug Dupixent (dupilumab) has been authorised by the FDA …

News

FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults

March 11, 2019
Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma

Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

News

Philippines Department of Justice recommends charges against six Sanofi officials

March 1, 2019
Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …

News

Sanofi’s Dupixent improves symptoms in rhinosinusitis with nasal polyps at Phase 3

February 27, 2019
Research and Development Dupixent, Sanofi, pharma, rhinosinusitis

New data has been released on Sanofi’s Dupixent (dupilumab), derived from two Phase 3 trials, illustrating the drug’s efficacy In …

News
shutterstock_274590824

Jury upholds Amgen’s patent validity for Repatha, deflecting challenge from Sanofi and Regeneron

February 26, 2019
Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, patent, pharma

Amgen is celebrating after a Delaware jury backed the validity of two of its patents against challenges from Regeneron and …

News

Philippines’ FDA halts sales of Sanofi’s dengue vaccine

February 19, 2019
Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …

News
white-house-13863_960_720

Pharma chiefs will testify at Senate hearing on rising drug prices

February 7, 2019
Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing

The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …

News

FDA approves first therapy for acquired thrombotic thrombocytopenic purpura: Sanofi’s Cablivi

February 7, 2019
Sales and Marketing Calblivi, FDA, Sanofi, acquired thrombotic thrombocytopenic purpura, pharma

Following swiftly on the heels of the previous success with the announcement of positive Phase 3 data for Icaria in …

News

Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3

February 6, 2019
Research and Development Icaria, Sanofi, multiple myeloma, pharma

Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …

News
ipos0_l

Sanofi will pay Regeneron $582m in deal restructuring

January 7, 2019
Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma

French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …

News
bi_microparts_image

Boehringer’s France restructure will cull over 300 jobs

December 11, 2018
Manufacturing and Production Boehringer, Sanofi, job cuts, pharma

Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit

Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …

News

Sanofi announce cull of 670 French jobs

December 6, 2018
Business Services, Manufacturing and Production CGT, France, Jobs, Macron, Sanofi, gilet jaunes, yellow jackets

French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025